Strides Pharma Science Ltd.

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1990

Chairman: Deepak Vaidya

Managing Director: --

Group: --

Listing: NSE: STAR, BSE: 532531

Headquarters: Navi Mumbai, Maharashtra

Website: www.stridesarco.com

Market cap: R 2,753.24 Cr

Revenue (TTM): R 2,973.03 Cr

Earnings (TTM): R 365.45 Cr

Cash: R 801.40 Cr

Total Debt: R 3,221.47 Cr

Promoters' ownership: 31.28%

Liquidity: High

52 Week range: R 268.00 - 547.65

Face value: R10.00

Shares outstanding: 8,95,65,464